SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the Month of November 2003
-----------------------
ELSCINT LIMITED
(Translation of Registrant's Name into English)
13 Mozes Street, Tel Aviv 67442, Israel
(Address of Principal Corporate Offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F:
|X| Form 20-F |_| Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1): |_|
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a
Form 6-K if submitted solely to provide an attached annual report to security
holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7): |_|
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a
Form 6-K submitted to furnish a report or other document that the registrant
foreign private issuer must furnish and make public under the laws of the
jurisdiction in which the registrant is incorporated, domiciled or legally
organized (the registrant's "home country"), or under the rules of the home
country exchange on which the registrant's securities are traded, as long as the
report or other document is not a press release, is not required to be and has
not been distributed to the registrant's security holders, and, if discussing a
material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.
Indicate by check mark whether the registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|_| Yes |X| No
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82-______________
Attached hereto as Exhibit 1 and incorporated herein by reference is
the Registrant's press release dated November 18, 2003.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
ELSCINT LIMITED
(Registrant)
By: /s/ Rachel Lavine
----------------------------
Name: Rachel Lavine
Title: President
Dated: November 19, 2003.
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
1. Press release dated November 18, 2003.
EXHIBIT 1
---------
Elscint Limited Signs Agreement for the Sale of Its 16% Interest In a Portfolio
- -------------------------------------------------------------------------------
Company
- -------
Tuesday November 18, 2:12 pm ET
TEL AVIV, Israel, Nov. 18 /PRNewswire-FirstCall/ -- Elscint Limited (NYSE: ELT -
NEWS; "Elscint") today announced that, within the framework of an agreement
dated November 17, 2003 for the sale of 100% of the outstanding shares of an
Israeli private company (which is engaged in the design, manufacture, sale and
service of Web enabled advanced solutions for medical imaging in health care
facilities), Elscint has sold all the shares and rights held by it in the said
company (approximately 16%, fully diluted) to an unrelated third party.
The closing of the transaction is expected to take place prior to the end of the
current year. As a consequence of this transaction, Elscint will record a
capital gain (before tax) of approximately $6 million in the fourth quarter of
2003.
Elscint Limited has interests in hotels in Western Europe, in hotel development
projects principally in Western and Central Europe and in the "Arena" commercial
and entertainment center at Herzlia Marina in Israel.
This release contains certain forward-looking statements which involve known and
unknown risks, uncertainties or other factors not under the Company's control
which may cause actual results, performance or achievements of the Company to be
materially different from the results, performance or other expectations implied
by these forward-looking statements. These factors include, but are not limited
to, those detailed in the Company's periodic filings with the Securities and
Exchange Commission.